Prediction of Midline Dose from Entrance and Exit Dose Using OSLD Measurements for Total Body Irradiation

  • Choi, Chang Heon (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Park, Jong Min (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Park, So-Yeon (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Chun, Minsoo (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Han, Ji Hye (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Cho, Jin Dong (Department of Radiation Oncology, Seoul National University Hospital) ;
  • Kim, Jung-in (Department of Radiation Oncology, Seoul National University Hospital)
  • Received : 2017.03.22
  • Accepted : 2017.05.11
  • Published : 2017.06.30


Background: This study aims to predict the midline dose based on the entrance and exit doses from optically stimulated luminescence detector (OSLD) measurements for total body irradiation (TBI). Materials and Methods: For TBI treatment, beam data sets were measured for 6 MV and 15 MV beams. To evaluate the tissue lateral effect of various thicknesses, the midline dose and peak dose were measured using a solid water phantom (SWP) and ion chamber. The entrance and exit doses were measured using OSLDs. OSLDs were attached onto the central beam axis at the entrance and exit surfaces of the phantom. The predicted midline dose was evaluated as the sum of the entrance and exit doses by OSLD measurement. The ratio of the entrance dose to the exit dose was evaluated at various thicknesses. Results and Discussion: The ratio of the peak dose to the midline dose was 1.12 for a 30 cm thick SWP at both energies. When the patient thickness is greater than 30 cm, the 15 MV should be used to ensure dose homogeneity. The ratio of the entrance dose to the exit dose was less than 1.0 for thicknesses of less than 30 cm and 40 cm at 6 MV and 15 MV, respectively. Therefore, the predicted midline dose can be underestimated for thinner body. At 15 MV, the ratios were approximately 1.06 for a thickness of 50 cm. In cases where adult patients are treated with the 15 MV photon beam, it is possible for the predicted midline dose to be overestimated for parts of the body with a thickness of 50 cm or greater. Conclusion: The predicted midline dose and OSLD-measured midline dose depend on the phantom thickness. For in-vivo dosimetry of TBI, the measurement dose should be corrected in order to accurately predict the midline dose.


Supported by : Ministry of Health & Welfare


  1. Keane T, Van Dyk JRider W. Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1981;7(10):1365-1370.
  2. Kim TH, Khan FMGalvin JM. A report of the work party: Comparison of total body irradiation techniques for bone marrow transplantation. Int. J. Radiat. Oncol. Biol. Phys. 1980;6(6):779-784.
  3. Appelbaum FR, Sullivan K, Buckner C, Clift R, Deeg HJ, Fefer A, Hill R, Mortimer J, Neiman PE, Sanders JE. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J. Clin. Oncol. 1987;5(9):1340-1347.
  4. Li R, Polishchuk A, DuBois S, Hawkins R, Lee SW, Bagatell R, Shusterman S, Hill-Kayser C. Patterns of relapse in high-risk neuroblastoma patients treated with and without total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2017;97(2):270-277.
  5. Reyzadeoglu M, Oysul K, Dirican B, Arpaci F, Balkan A, Surenkok S, Pak Y. Effect of dose-rate and lung dose in total body irradiation on interstitial pneumonitis after bone marrow transplantation. Tohoku J. Exp. Med. 2004;202(4):255-263.
  6. Kim MH, Rhu SY, Lim DS, Song JY. Effects of low-dose fractionated total body irradiation on murine immune system. J. Radiat. Prot. Res. 2014;39(3):134-141.
  7. Andreoli S, Bianchi C, Colleoni P, Fortunato M. Dosimetry in total body irradiation: A measurement set to characterize the treatment technique. Physica Med. 2016;32:1.
  8. Koch N, Jacqmin D, Mart C, Fugal M, Ashenafi M, Vanek K. Total body irradiation using dynamic arc delivery. Int. J. Radiat. Oncol. Biol. Phys. 2016;96(2):E640.
  9. Khan FM. The physics of radiation therapy. 3rd Ed. Philadelphia, PA. Williams and Wilkins. 2002;455-465.
  10. Satory P. Calculation of midplane dose for total body irradiation from entrance and exit dose MOSFET measurements. Australas. Phys. Eng. Sci. Med. 2012;35(1):101-104.
  11. Van Dyk J. Dosimetry for total body irradiation. Radiother. Oncol. 1987;9(2):107-118.
  12. Quast U. Whole body radiotherapy: A TBI-guideline. J. Med. Phys. 2006;31(1):5-12.
  13. Hui SK, Das RK, Thomadsen B, Henderson D. CT based analysis of dose homogeneity in total body irradiation using lateral beam. J. Appl. Clin. Med. Phys. 2004;5(4):71-79.
  14. Akino Y, McMullen KP, Das IJ. Patterns of patient specific dosimetry in total body irradiation. Med. Phys. 2013;40(4):01479 1-5.
  15. Zhu X. Entrance dose measurements for in-vivo diode dosimetry: Comparison of correction factors for two types of commercial silicon diode detectors. J. Appl. Clin. Med. Phys. 2000;1(3):100-107.
  16. Mrcela I, Bokulic T, Izewska J, Budanec M, Frobe AKusic Z. Optically stimulated luminescence in vivo dosimetry for radiotherapy: physical characterization and clinical measurements in $^{60}Co$ beams. Phys. Med. Biol. 2011;56(18):60-65.
  17. Jursinic PA. Characterization of optically stimulated luminescent dosimeters, OSLDs, for clinical dosimetric measurements. Med. Phys. 2007;34(12):4594-4604.
  18. Jursinic PA. Changes in optically stimulated luminescent dosimeter (OSLD) dosimetric characteristics with accumulated dose. Med. Phys. 2010;37(1):132-140.